 | Up a level |
Läppchen, Tilman; Bilinska, Adrianna; Pilatis, Eirinaios; Menéndez, Elena; Imlimthan, Surachet; Moon, Euy Sung; Afshar-Oromieh, Ali; Rösch, Frank; Rominger, Axel; Gourni, Eleni (2024). Tailoring Fibroblast-Activation Protein Targeting for Theranostics: A Comparative Preclinical Evaluation of the 68Ga- and 177Lu-Labeled Monomeric and Dimeric Fibroblast-Activation Protein Inhibitors DOTA.SA.FAPi and DOTAGA.(SA.FAPi)2. Molecules, 29(13) MDPI 10.3390/molecules29133093
D'Onofrio, Alice; Engelbrecht, Swantje; Läppchen, Tilman; Rominger, Axel; Gourni, Eleni (2023). GRPR-targeting radiotheranostics for breast cancer management. Frontiers in medicine, 10, p. 1250799. Frontiers 10.3389/fmed.2023.1250799
Imlimthan, Surachet; Menéndez, Elena; Escudero-Castellanos, Alondra; Moon, Euy Sung; Läppchen, Tilman; Rathke, Hendrik; Afshar-Oromieh, Ali; Roesch, Frank; Rominger, Axel; Gourni, Eleni (2022). Investigation of 68Ga/177Lu-labeled FAP-based inhibitor for diagnostic and therapeutic applications. Nuclear medicine and biology, 108-109, S56-S57. Elsevier 10.1016/S0969-8051(22)00147-0
Escudero-Castellanos, Alondra; Imlimthan, Surachet; Menéndez, Elena; Moon, Euy Sung; Läppchen, Tilman; Rathke, Hendrik; Afshar Oromieh, Ali; Roesch, Frank; Rominger, Axel; Gourni, Eleni (2022). Tumor stroma diagnostic imaging by a 68Ga-coupled small-molecule fibroblast activation protein (FAP) inhibitor: first pre-clinical data. Nuclear medicine and biology, 108-109, S186-S187. Elsevier 10.1016/S0969-8051(22)00388-2
Imlimthan, S.; Menéndez, E.; Escudero-Castellanos, A.; Moon, E.S.; Läppchen, T.; Rathke, H.; Afshar Oromieh, A.; Röesch, F.; Rominger, A.; Gourni, E. (2022). Preclinical evaluation of a 68Ga-labeled squaric acid-based FAP inhibitor for PET applications. Nuklearmedizin, 61(02), pp. 165-166. Thieme 10.1055/s-0042-1746024
Birindelli, G.; Drobnjakovic, M.; Morath, V.; Alessandria, C.D.; Gourni, E.; Afshar-Oromieh, A.; Weber, W.; Rominger, A.; Eiber, M.; Shi, K. (2022). In silico study on the heterogeneity of the dose distribution and radiobiological efficacy of Ac-225 and Lu-177 for PSMA-guided radiotherapy. Nuklearmedizin, 61(02), pp. 175-176. Thieme 10.1055/s-0042-1746053
Birindelli, Gabriele; Drobnjakovic, Milos; Morath, Volker; Steiger, Katja; D'Alessandria, Calogero; Gourni, Eleni; Afshar-Oromieh, Ali; Weber, Wolfgang; Rominger, Axel; Eiber, Matthias; Shi, Kuangyu (2021). In silico study on radiobiological efficacy of Ac-225 and Lu-177 for PSMA-guided radiotherapy. Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), 2021, pp. 4497-4500. IEEE 10.1109/EMBC46164.2021.9630297
Imlimthan, Surachet; Moon, Euy Sung; Rathke, Hendrik; Afshar-Oromieh, Ali; Rösch, Frank; Rominger, Axel; Gourni, Eleni (2021). New Frontiers in Cancer Imaging and Therapy Based on Radiolabeled Fibroblast Activation Protein Inhibitors: A Rational Review and Current Progress. Pharmaceuticals, 14(10) MDPI 10.3390/ph14101023
Alberts, Ian; Niklas-Hünermund, Jan; Sachpekidis, Christos; Zacho, Helle Damgaard; Mingels, Clemens; Dijkstra, Lotte; Bohn, Karl Peter; Läppchen, Tilman; Gourni, Eleni; Rominger, Axel; Afshar-Oromieh, Ali (2021). Combination of Forced Diuresis with Additional Late Imaging in 68Ga-PSMA-11 PET/CT: Effects on Lesion Visibility and Radiotracer Uptake. Journal of nuclear medicine, 62(9), pp. 1252-1257. Society of Nuclear Medicine 10.2967/jnumed.120.257741
Birindelli, Gabriele; Drobnjakovic, Milos; Morath, Volker; Steiger, Katja; D'Alessandria, Calogero; Gourni, Eleni; Afshar-Oromieh, Ali; Weber, Wolfgang; Rominger, Axel; Eiber, Matthias; Shi, Kuangyu (2021). Is Hypoxia a Factor Influencing PSMA-Directed Radioligand Therapy?-An In Silico Study on the Role of Chronic Hypoxia in Prostate Cancer. Cancers, 13(14) MDPI AG 10.3390/cancers13143429
Hofstetter, Michael; Moon, Euy Sung; D'Angelo, Fabio; Geissbühler, Lucien; Alberts, Ian; Afshar-Oromieh, Ali; Rösch, Frank; Rominger, Axel; Gourni, Eleni (2020). Effect of the versatile bifunctional chelator AAZTA5 on the radiometal labelling properties and the in vitro performance of a gastrin releasing peptide receptor antagonist. EJNMMI radiopharmacy and chemistry, 5(1), p. 29. Springer 10.1186/s41181-020-00115-8
Alberts, Ian; Sachpekidis, Christos; Dijkstra, Lotte; Prenosil, George; Gourni, Eleni; Boxler, Silvan; Gross, Tobias; Thalmann, George; Rahbar, Kambiz; Rominger, Axel; Afshar-Oromieh, Ali (2020). The role of additional late PSMA-ligand PET/CT in the differentiation between lymph node metastases and ganglia. European journal of nuclear medicine and molecular imaging, 47(3), pp. 642-651. Springer-Verlag 10.1007/s00259-019-04552-9
Alberts, Ian; Sachpekidis, Christos; Gourni, Eleni; Boxler, Silvan; Gross, Tobias; Thalmann, George; Rahbar, Kambiz; Rominger, Axel; Afshar Oromieh, Ali (2020). Dynamic patterns of [68Ga]Ga-PSMA-11 uptake in recurrent prostate cancer lesions. European journal of nuclear medicine and molecular imaging, 47(1), pp. 160-167. Springer-Verlag 10.1007/s00259-019-04545-8
Mix, Michael; Reichel, Kathrin; Stoykow, Christian; Bartholomä, Mark; Drendel, Vanessa; Gourni, Eleni; Wetterauer, Ulrich; Schultze-Seemann, Wolfgang; Meyer, Philipp T.; Jilg, Cordula A. (2018). Performance of 111In-labelled PSMA ligand in patients with nodal metastatic prostate cancer: correlation between tracer uptake and histopathology from lymphadenectomy. European journal of nuclear medicine and molecular imaging, 45(12), pp. 2062-2070. Springer-Verlag 10.1007/s00259-018-4094-0
